TL;DR
Mubadala Capital has exited its minority stake in Arcadia Consumer Healthcare, with majority owner Bansk Group assuming full control through a continuation vehicle backed by Coller Capital and...
TL;DR
Merck & Co. terminated acquisition talks with Revolution Medicines for a potential $28-32 billion deal, causing Revolution's stock to plunge 20%. The collapse stemmed from a valuation...
TL;DR
BioCryst Pharmaceuticals Inc. completed its all-cash acquisition of Astria Therapeutics Inc. for $700 million on January 23, 2026. This transaction significantly enhances BioCryst's leadership...
The Clorox Company has agreed to acquire GOJO Industries, the Ohio-based manufacturer of Purell hand sanitizer and skin health products, in an all-cash transaction valued at $2.25 billion. The deal...
TL;DR
Former executives of an unnamed health tech company that went public via a SPAC merger have agreed to a $10 million settlement to resolve investor lawsuits. The claims alleged executives...
TL;DR
GSK is set to acquire clinical-stage biotech Rapt Therapeutics for $2.2 billion in equity, or $58 per share in cash, with a net cash commitment of $1.9 billion. This acquisition grants GSK...
TL;DR
AstraZeneca's CFO outlined a disciplined M&A strategy, prioritizing bolt-on acquisitions under $5 billion in oncology and rare diseases, while actively scouting for preclinical assets in...
Sanofi is revising its takeover offer for Ocular Therapeutix after the U.S. biotech rejected the French drugmaker's initial $16 per share proposal, according to recent filings and market reports. ...
```html Boston Scientific Acquires Penumbra In $14.5 Billion Bet To Dominate Thrombectomy body { font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', 'Helvetica Neue', sans-serif; line-height:...
Johnson & Johnson (NYSE: JNJ) secured a partial victory from Delaware's Supreme Court, overturning a key element of a $1 billion damages award tied to its 2019 $3.4 billion acquisition of...
